GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BrightPath Biotherapeutics Co Ltd (TSE:4594) » Definitions » FCF Yield %

BrightPath Biotherapeutics Co (TSE:4594) FCF Yield % : -30.79 (As of Apr. 28, 2024)


View and export this data going back to 2015. Start your Free Trial

What is BrightPath Biotherapeutics Co FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BrightPath Biotherapeutics Co's Trailing 12-Month Free Cash Flow is 円-1,206.16 Mil, and Market Cap is 円3,917.09 Mil. Therefore, BrightPath Biotherapeutics Co's FCF Yield % for today is -30.79%.

The historical rank and industry rank for BrightPath Biotherapeutics Co's FCF Yield % or its related term are showing as below:

TSE:4594' s FCF Yield % Range Over the Past 10 Years
Min: -32.44   Med: 0   Max: 0
Current: -30.79


TSE:4594's FCF Yield % is ranked worse than
65.74% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs TSE:4594: -30.79

BrightPath Biotherapeutics Co's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


BrightPath Biotherapeutics Co FCF Yield % Historical Data

The historical data trend for BrightPath Biotherapeutics Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BrightPath Biotherapeutics Co FCF Yield % Chart

BrightPath Biotherapeutics Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only -12.62 -20.74 -18.22 -26.88 -11.15

BrightPath Biotherapeutics Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BrightPath Biotherapeutics Co's FCF Yield %

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BrightPath Biotherapeutics Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's FCF Yield % falls into.



BrightPath Biotherapeutics Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BrightPath Biotherapeutics Co's FCF Yield % for the fiscal year that ended in Mar. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-1206.161 / 10817.2864
=-11.15%

BrightPath Biotherapeutics Co's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 5641.1931
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BrightPath Biotherapeutics Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BrightPath Biotherapeutics Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BrightPath Biotherapeutics Co (TSE:4594) Business Description

Traded in Other Exchanges
N/A
Address
2-2-4 Kojimachi, Kojimachi Central Building 7th Floor, Chiyoda-ku, Tokyo, JPN
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

BrightPath Biotherapeutics Co (TSE:4594) Headlines

No Headlines